viernes, 27 de diciembre de 2024

Modifications to Labeling of Buprenorphine-Containing Transmucosal Products for the Treatment of Opioid Dependence

https://www.federalregister.gov/documents/2024/12/27/2024-30776/modifications-to-labeling-of-buprenorphine-containing-transmucosal-products-for-the-treatment-of

No hay comentarios: